Novartis's spinoff of its eyecare division Alcon, set for Tuesday April 9, marks the largest Swiss stock deal in a decade and forces a reshuffle of the benchmark Swiss Market Index (SMI) as private bank Julius Baer gets booted out.
from Reuters: New Issues News https://ift.tt/2OHti5s
Tidak ada komentar:
Posting Komentar